Teva Pharmaceutical Industries ADR
(TEVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,099,000 | -1,000,000 | -2,472,000 | -16,449,000 | 311,000 |
| Depreciation Amortization | 1,557,000 | 1,722,000 | 1,842,000 | 2,112,000 | 1,524,000 |
| Income taxes - deferred | -696,000 | -985,000 | -837,000 | -2,331,000 | 15,000 |
| Accounts receivable | N/A | -394,000 | 88,000 | N/A | 343,000 |
| Other Working Capital | -2,188,000 | -896,000 | -1,823,000 | -1,645,000 | 1,219,000 |
| Other Operating Activity | 6,642,000 | 2,301,000 | 5,648,000 | 20,538,000 | 1,813,000 |
| Operating Cash Flow | $1,216,000 | $748,000 | $2,446,000 | $2,225,000 | $5,225,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -511,000 | -182,000 | 239,000 | 2,603,000 | 1,101,000 |
| Net Acquisitions | N/A | N/A | N/A | 43,000 | -36,148,000 |
| Purchase Of Investment | -55,000 | -8,000 | -119,000 | -200,000 | -481,000 |
| Sale Of Investment | 12,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 1,417,000 | 1,545,000 | 1,746,000 | 1,000,000 | -212,000 |
| Investing Cash Flow | $863,000 | $1,355,000 | $1,866,000 | $3,446,000 | $-35,740,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 550,000 | 500,000 | -260,000 | -1,683,000 | 1,998,000 |
| Debt Issued | N/A | 2,083,000 | 4,434,000 | -2,794,000 | 25,581,000 |
| Debt Repayment | -1,871,000 | -3,944,000 | -7,446,000 | N/A | -999,000 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 364,000 |
| Dividend Paid | N/A | N/A | -22,000 | -1,199,000 | -1,558,000 |
| Other Financing Activity | -564,000 | -565,000 | -57,000 | -74,000 | -169,000 |
| Financing Cash Flow | $-1,885,000 | $-1,926,000 | $-3,351,000 | $-5,750,000 | $25,217,000 |
| Exchange Rate Effect | 8,000 | 16,000 | -142,000 | 54,000 | -660,000 |
| Beginning Cash Position | 1,975,000 | 1,782,000 | 963,000 | 988,000 | 6,946,000 |
| End Cash Position | 2,177,000 | 1,975,000 | 1,782,000 | 963,000 | 988,000 |
| Net Cash Flow | $202,000 | $193,000 | $819,000 | $-25,000 | $-5,958,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,216,000 | 748,000 | 2,446,000 | 2,225,000 | 5,225,000 |
| Capital Expenditure | -578,000 | -525,000 | -651,000 | -874,000 | -901,000 |
| Free Cash Flow | 638,000 | 223,000 | 1,795,000 | 1,351,000 | 4,324,000 |